Literature DB >> 8650885

Renal cryoablation in a canine model.

R A Stephenson1, D K King, L R Rohr.   

Abstract

OBJECTIVES: To assess the potential safety and utility of cryoablation for treatment of selected renal tumors in a canine model.
METHODS: Ultrasound and direct physical measurements (depth and width) of five cryolesions were compared. Cryolesions were examined histologically in 6 animals, which were killed at 4 hours, 2 days, 1 week, 3 weeks, 6 weeks, and 12 weeks. Mortality/morbidity was assessed in 12 animals over a 1-month interval, where 6 animals received small (approximately 2 cm) cryolesions and 6 animals received large (one third to one half of kidney) cryolesions. Laparoscopic cryoablation was performed in 2 animals.
RESULTS: A statistically significant association of physical and ultrasound dimensions was observed (correlation coefficient R = 0.9295; P = 0.0001). Histologic studies in animals killed up to 1 week after cryoablation revealed complete coagulative necrosis within the cryolesion. The boundary transition from normal to complete tissue necrosis occurred in 1 to 2 mm. Animals killed 3 weeks to 3 months after cryoablation revealed progressive organization with granulation tissue, chronic inflammation, hemosiderosis, fibrosis, and contraction of the cryolesion with parenchymal loss. Untreated renal tissue was histologically normal in all kidneys. No mortality or morbidity was detected in the 12 animals followed for 30 days regardless of the size of the cryolesion. Laparoscopic cryoablation was performed successfully in 2 animals without modification of standard laparoscopic methods.
CONCLUSIONS: Sonographic, histologic, and laparoscopic data in a canine model suggest that cryoablation may be a safe, feasible, and useful method for treatment of selected renal neoplasms.

Entities:  

Mesh:

Year:  1996        PMID: 8650885     DOI: 10.1016/s0090-4295(96)00028-3

Source DB:  PubMed          Journal:  Urology        ISSN: 0090-4295            Impact factor:   2.649


  8 in total

1.  Optimal freeze cycle length for renal cryotherapy.

Authors:  Jennifer Lee Young; Elham Khanifar; Navneet Narula; Cervando Gerardo Ortiz-Vanderdys; Surendra Babu Kolla; Donald Lowell Pick; Petros George Sountoulides; Oskar Grau Kaufmann; Kathryn Elizabeth Osann; Victor Buu Huynh; Adam Geoffrey Kaplan; Lorena Aurora Andrade; Michael Ken Louie; Elspeth Marguerita McDougall; Ralph Victor Clayman
Journal:  J Urol       Date:  2011-05-20       Impact factor: 7.450

2.  Laparoscopic and percutaneous ablative techniques in the treatment of renal cell carcinoma.

Authors:  Kent Perry; Amnon Zisman; Allan J Pantuck; Nicolette Janzen; Peter Schulam; Arie S Belldegrun
Journal:  Rev Urol       Date:  2002

3.  Ablative therapies for renal tumors.

Authors:  Rajan Ramanathan; Raymond J Leveillee
Journal:  Ther Adv Urol       Date:  2010-04

Review 4.  Radiofrequency ablation of renal tumors.

Authors:  Andreas H Mahnken; Rolf W Günther; Josef Tacke
Journal:  Eur Radiol       Date:  2004-05-19       Impact factor: 5.315

Review 5.  Contrast-Enhanced Transrectal Ultrasound in Focal Therapy for Prostate Cancer.

Authors:  Akbar N Ashrafi; Nima Nassiri; Inderbir S Gill; Mittul Gulati; Daniel Park; Andre L de Castro Abreu
Journal:  Curr Urol Rep       Date:  2018-08-28       Impact factor: 2.862

Review 6.  Minimally invasive ablative approaches in the treatment of renal cell carcinoma.

Authors:  Nicolette Janzen; Amnon Zisman; Allan J Pantuck; Kent Perry; Peter Schulam; Arie S Belldegrun
Journal:  Curr Urol Rep       Date:  2002-02       Impact factor: 2.862

Review 7.  Laparoscopic partial nephrectomy and minimally invasive nephron-sparing surgery.

Authors:  Michael W Phelan; Kent T Perry; John Gore; Peter G Schulam
Journal:  Curr Urol Rep       Date:  2003-02       Impact factor: 2.862

Review 8.  Update on minimally invasive approaches to kidney tumors.

Authors:  Jonathan J Hwang; McClellan M Walther
Journal:  Curr Urol Rep       Date:  2004-02       Impact factor: 2.862

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.